Skip to main content

Advertisement

Log in

Letter to the Editor

  • Published:
Theoretical Medicine and Bioethics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Beauchamp, T, H.R. Ferdowsian, and J.P. Gluck. 2014. Rethinking the ethics of research involving nonhuman animals. Special issue. Theoretical Medicine and Bioethics 38(2): 91–185.

  2. Choe Smith, C.U. 2014. Confronting ethical permissibility in animal research: Rejecting a common assumption and extending a principle of justice. Theoretical Medicine and Bioethics 35(2): 175–185.

    Article  Google Scholar 

  3. Platt, J.R. 1964. Strong inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others. Science 146(3642): 347–353.

    Article  Google Scholar 

  4. LaFollette, H., and N. Shanks. 1996. Brute science: Dilemmas of animal experimentation. London: Routledge.

    Google Scholar 

  5. Greek, R., and N. Shanks. 2009. FAQs about the use of animals in science: A handbook for the scientifically perplexed. Lanham: University Press of America.

    Google Scholar 

  6. Greek, R., and N. Shanks. 2011. Complex systems, evolution, and animal models. Studies in History and Philosophy of Biological and Biomedical Sciences 42(4): 542–544.

    Article  Google Scholar 

  7. Greek, R., N. Shanks, and M.J. Rice. 2011. The history and implications of testing thalidomide on animals. The Journal of Philosophy, Science & Law 11. http://jpsl.org/archives/history-and-implications-testing-thalidomide-animals/. Accessed August 5, 2014.

  8. Shanks, N., and R. Greek. 2008. Experimental use of nonhuman primates is not a simple problem. Nature Medicine 14(10): 807–808.

    Article  Google Scholar 

  9. Shanks, N., and R. Greek. 2009. Animal models in light of evolution. Boca Raton: Brown Walker.

    Google Scholar 

  10. Shanks, N., R. Greek, and J. Greek. 2009. Are animal models predictive for humans? Philosophy, Ethics, and Humanities in Medicine 4: 2. doi:10.1186/1747-5341-4-2.

    Article  Google Scholar 

  11. Greek, R. 2012. Animal models and the development of an HIV vaccine. Journal of AIDS & Clinical Research S8: 001. doi:10.4172/2155-6113.S8-001.

    Google Scholar 

  12. Greek, R. 2012. Review of Zoobiquity: What animals can teach us about health and the science of healing, by B. Natterson-Horowitz and K. Bowers. Animals 2(4): 559–563.

    Article  Google Scholar 

  13. Greek, R., A. Menache, and M.J. Rice. 2012. Animal models in an age of personalized medicine. Personalized Medicine 9(1): 47–64.

    Article  Google Scholar 

  14. Greek, R., A. Pippus, and L.A. Hansen. 2012. The Nuremberg Code subverts human health and safety by requiring animal modeling. BMC Medical Ethics 13: 16. doi:10.1186/1472-6939-13-16.

    Article  Google Scholar 

  15. Greek, R., and M.J. Rice. 2012. Animal models and conserved processes. Theoretical Biology and Medical Modelling 9: 40. doi:10.1186/1742-4682-9-40.

    Article  Google Scholar 

  16. Greek, R. 2013. Animal models of cancer in light of evolutionary biology and complexity science. In The research and biology of cancer. Hong Kong: iConcept Press Ltd.

  17. Greek, R. 2013. Animal models in drug development. In New insights into toxicity and drug testing, ed. Sivakumar Gowder, 124–152. Manhattan: InTech.

    Google Scholar 

  18. Greek, R., and L.A. Hansen. 2013. The strengths and limits of animal models as illustrated by the discovery and development of antibacterials. Biological Systems 2: 2. doi:10.4172/BSO.1000109.

    Google Scholar 

  19. Greek, R., and L.A. Hansen. 2013. Questions regarding the predictive value of one evolved complex adaptive system for a second: Exemplified by the SOD1 mouse. Progress in Biophysics and Molecular Biology 113: 231–253.

    Article  Google Scholar 

  20. Greek, R., and A. Menache. 2013. Systematic reviews of animal models: Methodology versus epistemology. International Journal of Medical Sciences 10: 206–221.

    Article  Google Scholar 

  21. Jones, R.C., and R. Greek. 2013. A review of the Institute of Medicine’s analysis of using chimpanzees in biomedical research. Science and Engineering Ethics 20: 481–504.

    Article  Google Scholar 

  22. Curry, S.H. 2003. Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Annals of the New York Academy of Sciences 993: 69–74.

    Article  Google Scholar 

  23. Macleod, M. 2004. Systematic review and meta-analysis of experimental stroke. International Journal of Neuroprotection and Neuroregeneration 1: 9–12.

    Google Scholar 

  24. Kaste, M. 2005. Use of animal models has not contributed to development of acute stroke therapies: Pro. Stroke 36(10): 2323–2324.

    Article  Google Scholar 

  25. O’Collins, V.E., M.R. Macleod, G.A. Donnan, L.L. Horky, B.H. van der Worp, and D.W. Howells. 2006. 1,026 experimental treatments in acute stroke. Annals of Neurology 59(3): 467–477.

    Article  Google Scholar 

  26. Sena, E., H.B. van der Worp, D. Howells, and M. Macleod. 2007. How can we improve the pre-clinical development of drugs for stroke? Trends in Neurosciences 30(9): 433–439.

    Article  Google Scholar 

  27. Ginsberg, M.D. 2008. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55(3): 363–389.

    Article  Google Scholar 

  28. Feuerstein, G.Z., and J. Chavez. 2009. Translational medicine for stroke drug discovery: The pharmaceutical industry perspective. Stroke 40: S121–S125.

    Article  Google Scholar 

  29. Sena, E.S., H.B. van der Worp, P.M.W. Bath, D.W. Howells, and M.R. Macleod. 2010. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biology 8(3): e1000344.

    Article  Google Scholar 

  30. O’Collins, V.E., M.R. Macleod, S.F. Cox, L. van Raay, E. Aleksoska, G.A. Donnan, and D.W. Howells. 2011. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. Journal of Cerebral Blood Flow and Metabolism 31(3): 962–975.

    Article  Google Scholar 

  31. Editorial. 2007. Cold shower for AIDS vaccines. Nature Medicine 13(12):1389–1390.

  32. Buchbinder, S.P., D.V. Mehrotra, A. Duerr, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881–1893.

    Article  Google Scholar 

  33. Gamble, L.J., and Q.L. Matthews. 2010. Current progress in the development of a prophylactic vaccine for HIV-1. Drug Design, Development and Therapy 5(9–26): 33.

    Google Scholar 

  34. Chu, B.C., C.C. Fan, and S.B. Howell. 1981. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. Journal of the National Cancer Institute 66: 121–124.

    Google Scholar 

  35. Greenstein, J.P. 1954. Biochemistry of cancer, 2nd ed. New York: Academic Press.

    Google Scholar 

  36. Janofsky, M. 1993. On cigarettes, health and lawyers. New York Times, December 6. http://www.nytimes.com/1993/12/06/business/on-cigarettes-health-and-lawyers.html. Accessed April 17, 2014.

  37. Lindsay, M.A. 2005. Finding new drug targets in the 21st century. Drug Discovery Today 10: 1683–1687.

    Article  Google Scholar 

  38. Northrup, E. 1957. Science looks at smoking: A new inquiry into the effects of smoking on your health. New York: Coward-McCann.

    Google Scholar 

  39. Utidjian, M. 1988. The interaction between epidemiology and animal studies in industrial toxicology. In Perspectives in basic and applied toxicology, ed. B. Ballantyne, 309–329. London: Butterworth-Heinemann.

    Google Scholar 

  40. Gardner, Leroy U. 1938. Etiology of pneumoconiosis. Journal of the American Medical Association 111: 1925–1936.

    Article  Google Scholar 

  41. Gross, P. 1977. The biologic response to inhaled mineral fibers: Facts and fancies. Reviews on Environmental Health 2(3): 167–175.

    Google Scholar 

  42. Muhle, H., and F. Pott. 2000. Asbestos as reference material for fibre-induced cancer. International Archives of Occupational and Environmental Health 73: S53–S59.

    Article  Google Scholar 

  43. Oberdorster, G. 1996. Evaluation and use of animal models to assess mechanisms of fibre carcinogenicity. IARC Scientific 140: 107–125.

    Google Scholar 

  44. Smith, W.E., L. Miller, R.E. Elsasser, and D.D. Hubert. 1965. Tests for carcinogenicity of asbestos. Annals of the New York Academy of Sciences 132(1): 456–488.

    Article  Google Scholar 

  45. Wagner, J.C. 1963. Asbestosis in experimental animals. British Journal of Industrial Medicine 20: 1–12.

    Google Scholar 

  46. Wagner, J.C., G. Berry, J.W. Skidmore, and V. Timbrell. 1974. The effects of the inhalation of asbestos in rats. British Journal of Cancer 29(3): 252–269.

    Article  Google Scholar 

  47. KMR Group. 2012. R&D performance. http://www.kmrgroup.com/PressReleases/2012_08_08KMRPBFSuccessRate&CycleTimePressRelease.pdf. Accessed July 12, 2013.

  48. Heywood, R. 1981. Target organ toxicity. Toxicology Letters 8(6): 349–358.

    Article  Google Scholar 

  49. Eason, C.T., F.W. Bonner, and D.V. Parke. 1990. The importance of pharmacokinetic and receptor studies in drug safety evaluation. Regulatory Toxicology and Pharmacology 11(3): 288–307.

    Article  Google Scholar 

  50. Lin, J.H. 1995. Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition 23(10): 1008–1021.

    Google Scholar 

  51. Li, A.P. 2004. Accurate prediction of human drug toxicity: A major challenge in drug development. Chemico-Biological Interactions 150: 3–7.

    Article  Google Scholar 

  52. Geerts, H. 2009. Of mice and men: Bridging the translational disconnect in CNS drug discovery. CNS Drugs 23(11): 915–926.

    Article  Google Scholar 

  53. Collins, F.S. 2011. Reengineering translational science: The time is right. Science Translational Medicine 3(90):90cm17. doi:10.1126/scitranslmed.3002747.

  54. Giri, S., and A. Bader. 2011. Foundation review: Improved preclinical safety assessment using micro-BAL devices: The potential impact on human discovery and drug attrition. Drug Discovery Today 16: 382–397.

    Article  Google Scholar 

  55. van Meer, P.J.K., M. Kooijman, C.C. Gispen-de Wied, E.H.M. Moors, and H. Schellekens. 2012. The ability of animal studies to detect serious post marketing adverse events is limited. Regulatory Toxicology and Pharmacology 64(3): 345–349.

    Article  Google Scholar 

  56. Greek, R., and J. Greek. 2010. Is the use of sentient animals in basic research justifiable? Philosophy, Ethics, and Humanities in Medicine 5: 14. doi:10.1186/1747-5341-5-14.

    Article  Google Scholar 

  57. Begley, S. 2003. Physician-researchers needed to get cures out of rat’s cage. Wall Street Journal, April 25. http://online.wsj.com/news/articles/SB105121836549788500.

  58. Contopoulos-Ioannidis, D.G., E. Ntzani, and J.P. Ioannidis. 2003. Translation of highly promising basic science research into clinical applications. American Journal of Medicine 114(6): 477–484.

    Article  Google Scholar 

  59. Crowley Jr., W.F. 2003. Translation of basic research into useful treatments: How often does it occur? American Journal of Medicine 114(6): 503–505.

    Article  Google Scholar 

  60. Editorial. 2010. Hope in translation. Nature 467(7315):499.

  61. Editorial. 2012. Must try harder. Nature 483(7391):509.

  62. Hackam, D.G., and D.A. Redelmeier. 2006. Translation of research evidence from animals to humans. Journal of the American Medical Association 296(14): 1731–1732.

    Google Scholar 

  63. Johnston, S.C. 2006. Translation: Case study in failure. Annals of Neurology 59(3): 447–448.

    Article  Google Scholar 

  64. Leslie, M. 2010. Biomedical research: Immunology uncaged. Science 327(5973): 1573.

    Article  Google Scholar 

  65. Mankoff, S.P., C. Brander, S. Ferrone, and F.M. Marincola. 2004. Lost in translation: Obstacles to translational medicine. Journal of Translational Medicine 2: 14. doi:10.1186/1479-5876-2-14.

    Article  Google Scholar 

  66. Marincola, F.M. 2003. Translational medicine: A two-way road. Journal of Translational Medicine 1: 1. doi:10.1186/1479-5876-1-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ray Greek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greek, R. Letter to the Editor. Theor Med Bioeth 35, 389–394 (2014). https://doi.org/10.1007/s11017-014-9305-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11017-014-9305-5

Keywords

Navigation